Physician profile
Jerod L Lunsford
NPI 1891828133
$2,308.15
in general payments reported to CMS, 2019-2025
16 companies · $751 in 2025
The $751 reported for 2025 was more than what 82% of Undersea and Hyperbaric Medicine (Preventive Medicine) providers received nationally (typical 2025 total: $210).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.11 · 2023: $338 · 2024: $1,205 · 2025: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,294.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $586.92 | 2023-2025 | Grafix Pl, Grafix, Oasis |
| Kerecis Limited | $453.23 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Organogenesis INC. | $260.79 | 2024-2025 | Puraply Wound Matrix, Apligraf, Affinity |
| Convatec INC. | $171.54 | 2024 | |
| Paratek Pharmaceuticals, INC. | $158.35 | 2024 | Nuzyra |
| Cashflow Solutions, LLC | $142.74 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Mimedx Group, INC. | $141.36 | 2024 | |
| Sequel Med Tech, LLC | $75.21 | 2025 | Twiist |
| Next Science LLC | $71.05 | 2023 | Surgx, Blastx, Xperience |
| Solventum Corporation | $67.23 | 2024-2025 | Activ.A.C., V.A.C. Dermatac |
| Abbvie INC. | $54.23 | 2023-2024 | |
| Hydrofera LLC | $49.86 | 2023-2024 | Hydrofera Blue, Hydrofera Blue Ready - Border |
| Aroa Biosurgery Incorporated | $25.66 | 2025 | |
| Urgo Medical North America, LLC | $19.88 | 2024 | Urgok2 |
| Advanced Oxygen Therapy INC. | $15.99 | 2025 | Topical Oxygen Chamber For Extremities |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerod Lunsford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.